HIGHLIGHTS
- What: The main reason in choosing OVA as a drug carrier is advantages like easy access to its sources and its low price.
- Who: Vishal Jadhav from the (UNIVERSITY) have published the research work: International Journal for Multidisciplinary Research (IJFMR), in the Journal: (JOURNAL)
SUMMARY
In the animal model of overexpressing breast cancer, albumin nanoparticles increased target effectiveness and extended survival. Nanotechnology has revolutionized medical sciences, enabling the development of nanoparticle drug delivery systems (DDS) that overcome traditional drug delivery challenges. Nucleic acid-based nanoparticles These innovative platforms aim to improve . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.